New cancer clinical trial: METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

Published on: January 01, 2018 at 10:00AM
Condition:   Colorectal Neoplasms Malignant
Interventions:   Drug: Nivolumab;   Drug: FLOX
Sponsors:   University Hospital, Akershus;   Trondheim University Hospital;   Haukeland University Hospital;   Hospital of Southern Norway Trust;   Oslo University Hospital
Not yet recruiting
http://ift.tt/2qfCsxH